You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健友股份(603707.SH):苯磺順阿曲庫銨注射液獲藥品註冊證書
格隆匯 12-22 17:27

格隆匯12月22日丨健友股份(603707.SH)公佈,公司於近日收到國家藥監局關於核准簽發苯磺順阿曲庫銨注射液(規格:5ml:10mg)藥品註冊證書的通知(藥品批准文號:國藥準字H20203700)。

苯磺順阿曲庫銨注射液(Cisatracurium Besylate Injection)屬於肌鬆劑,具有通過非肝非腎途徑代謝的特點,肌鬆作用比苯磺酸阿曲庫銨作用強3倍。其具有起效快、作用強、恢復迅速、不釋放組胺、對心血管影響小、無蓄積、代謝產物無肌鬆效應也無毒性的臨牀優勢。主要適用於全身麻醉,並能廣泛應用在氣管插管、肝腎功能障礙、心血管手術及老年和兒科病人。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account